# Hydrolyzed Collagen from Salmon Skin Mitigates L-NAME-Induced Hypertension in Rats by Attenuating Oxidative Stress and Inflammation and Improving Vascular Remodeling

**Authors:** Pimchanok Mungmuang, Jiraporn Tocharus, Luckika Panthiya, Rattapong Sungnoon, Krisana Nilsuwan, Soottawat Benjakul, Chainarong Tocharus

PMC · DOI: 10.3390/ijms27062805 · International Journal of Molecular Sciences · 2026-03-19

## TL;DR

This study shows that hydrolyzed collagen from salmon skin can reduce high blood pressure in rats by lowering oxidative stress and inflammation and improving blood vessel health.

## Contribution

The study demonstrates the novel antihypertensive potential of salmon skin-derived hydrolyzed collagen in a rat model.

## Key findings

- HC at 450 mg/kg reduced systolic blood pressure, oxidative stress, and inflammatory cytokines in hypertensive rats.
- HC improved vascular function and aortic structure, as shown by histopathological and relaxation response analyses.
- Increased nitric oxide production was linked to better vascular function in HC-treated rats.

## Abstract

This study aimed to investigate whether hydrolyzed collagen (HC) derived from salmon skin could attenuate blood pressure and vascular damage in Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME)-induced hypertensive rats. Hypertension was induced in rats by the oral administration of L-NAME (40 mg/kg/day) for eight weeks, while HC in two doses (50, 450 mg/kg) or enalapril at 10 mg/kg dissolved in water were concurrently administered via oral gavage for the last four weeks. Treatment with HC (450 mg/kg) and enalapril resulted in a reduction in systolic blood pressure, oxidative stress markers, and inflammatory cytokines. Production of serum nitric oxide (NO) was also increased, contributing to better aortic function. Histopathological analysis confirmed these changes, showing enhanced progression in the aorta structure. Vascular function was improved, as evidenced by significantly higher relaxation responses to acetylcholine (ACh) in the presence or absence of endothelium. These findings indicate that HC effectively lowered the blood pressure in hypertensive rats, potentially through mechanisms involving the modulation of oxidative stress and the expression of nitric oxide, reducing vascular inflammation and remodeling, hence enhancing vascular function.

## Linked entities

- **Chemicals:** L-NAME (PubChem CID 39836), enalapril (PubChem CID 5388962)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Diseases:** Hypertension (MESH:D006973), Inflammation (MESH:D007249), vascular damage (MESH:D057772)
- **Chemicals:** ACh (MESH:D000109), enalapril (MESH:D004656), L-NAME (MESH:D019331), HC (-), NO (MESH:D009569)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13026407/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13026407/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC13026407/full.md

---
Source: https://tomesphere.com/paper/PMC13026407